Evidence Synthesis
VENMAX posted a strong quarterly performance, with its 9.2% gross margin accelerating to, up from 25.29%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 08:27
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
VENMAX posted a strong quarterly performance, with its 9.2% gross margin accelerating to, up from 25.29%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 9.2 % | 4.69 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 4.69 % | 3.52 | ▲ |
| REVENUE_GROWTH_YOY | 104.9 % | 40.8 | ▲ |
| PRICE_CHANGE_PERCENT | 4.462 % | — | - |
| DAILY_VOLUME | 12,037 shares | 6,428 | ▲ |
| CLOSE_PRICE | 14.75 INR | 14.12 | ▲ |